Which is better, AVAH or RMD?

On the Buffett-Fit framework, ResMed Inc. (RMD) currently grades higher than AVAH — 72/100 (B grade) vs 38/100 (D). That said, "better" depends on which framework you trust — AVAH wins on Peter Lynch; RMD wins on Warren Buffett, Benjamin Graham, Philip Fisher, Joel Greenblatt, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy AVAH or RMD?

This page is an educational comparison, not investment advice. Both AVAH and RMD are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is AVAH better than RMD for value investing?

On the Buffett-style value-investing framework, RMD currently grades higher — 72/100 vs 38/100, a 34-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between AVAH and RMD on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). AVAH currently scores 38/100 (D grade); RMD scores 72/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, AVAH or RMD?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. AVAH and RMD are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, AVAH or RMD?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are AVAH and RMD both Healthcare stocks?

Yes — both Aveanna Healthcare Holdings Inc. (AVAH) and ResMed Inc. (RMD) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this AVAH vs RMD comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Aveanna Healthcare Holdings

ResMed

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

AVAH

Market cap

$1.6B

Sector

Healthcare

RMD

ResMed

Market cap

$30.18B

Sector

Healthcare

Overall winner

ResMed RMD

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	AVAH	RMD	Winner
Warren Buffett	38D	72B	RMD
Benjamin Graham	57D	75B	RMD
Philip Fisher	35D	75B	RMD
Peter Lynch	69B	58C	AVAH
Joel Greenblatt	46D	47D	RMD
Charlie Munger	42D	69B	RMD
Terry Smith	31F	73B	RMD

Side-by-side metrics

Metric	AVAH	RMD
Market cap	$1.6B	$30.18B
P/E (TTM)	6.3x	19.6x
EV/EBIT	11.3x	17.1x
ROIC (TTM)	15.86%	19.63%
Gross margin	32.67%	61.69%
Net margin	10.37%	27.44%
Revenue CAGR 5y	9.73%	12.64%
EPS CAGR 5y	-	30.73%
Debt / Equity	6.3x	0.1x
Dividend yield	0.0%	1.14%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

AVAH leads on

P/E (TTM)6.3xvs 19.6x+68%
EV/EBIT11.3xvs 17.1x+34%

RMD leads on

Dividend yield1.14%vs 0.0%+100%
Debt / Equity0.1xvs 6.3x+98%
Market cap$30.18Bvs $1.6B+95%
Net margin27.44%vs 10.37%+62%

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Aveanna Healthcare Holdings

ResMed

Fit scores by strategy

Side-by-side metrics

Where each one wins

More like AVAH

More like RMD

Related on invest-like

Key terms in this analysis